FNDC5 and type 2 diabetes mellitus: In the human study, the patients with type 2 diabetes (T2D) had decreased serum irisin level and T2D drug metformin or glucagon-like peptide-1(GLP-1) treatments increased serum irisin level in the T2D patients8, 9.